Evidence map›Paper›PMID 39242171›Full record

ArticleBMJ open2024

Disability in childhood and the equity of health services: a cross-sectional comparison of mass drug administration strategies for soil-transmitted helminths in southern Malawi.

Stefan Witek-McManus, James Simwanza, Rejoice Msiska, Hastings Mangawah, William Oswald, Joseph Timothy, Sean Galagan, Emily Pearman, Mariyam Shaikh, Hugo Legge and 7 more

Registry-linked trialAbstract readComparative Study
In one paragraph

Article in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03014167 (Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03014167 phase3completednot on this map

Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths (STH) DeWorm3 Project

TypeinterventionalSponsorUniversity of WashingtonRan2017 to 2024Enrolled357,716ConditionsHelminthiasis, FilariasisArmsAlbendazole
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Stefan Witek-McManusDepartment of Disease Control, London School of Hygiene and Tropical Medicine, London, UK stefan.witek-mcmanus@lshtm.ac.uk.ORCID 0000-0002-1445-3567
James SimwanzaBlantyre Institute for Community Outreach, Blantyre, Malawi.
Rejoice MsiskaBlantyre Institute for Community Outreach, Blantyre, Malawi.
Hastings MangawahBlantyre Institute for Community Outreach, Blantyre, Malawi.
William OswaldDepartment of Disease Control, London School of Hygiene and Tropical Medicine, London, UK.
Joseph TimothyDepartment of Disease Control, London School of Hygiene and Tropical Medicine, London, UK.
Sean GalaganDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Emily PearmanDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Mariyam ShaikhDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Hugo LeggeDepartment of Disease Control, London School of Hygiene and Tropical Medicine, London, UK.
Judd WalsonDepartment of Global Health, University of Washington, Seattle, Washington, USA.ORCID 0000-0003-4836-720X
Lazarus JuziweloNational Schistosomiasis and STH Control Programme, Community Health Sciences Unit, Ministry of Health & Population, Lilongwe, Malawi.
Calum DaveyDepartment of Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Rachel PullanDepartment of Disease Control, London School of Hygiene and Tropical Medicine, London, UK.
Robin L BaileyDepartment of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK.
Khumbo KaluaBlantyre Institute for Community Outreach, Blantyre, Malawi.
Hannah KuperDepartment of Population Health, London School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0002-8952-0023

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSchool-based approaches are an efficient mechanism for the delivery of basic health services, but may result in the exclusion of children with disabilities if they are less likely to participate in schooling. Community-based 'door to door' approaches may provide a more equitable strategy to ensure that children with disabilities are reached, but disability is rarely assessed rigorously in the evaluation of health interventions.

objectivesTo describe the prevalence and factors associated with disability among children aged 5-17 years and to assess the relative effectiveness of routine school-based deworming (SBD) compared with a novel intervention of community-based deworming (CBD) in treating children with disabilities for soil-transmitted helminths.

settingDeWorm3 Malawi Site (DMS), Mangochi district, Malawi.

participantsAll 44 574 children aged 5-17 years residing within the DMS. PRIMARY AND SECONDARY OUTCOME MEASURES: Disability was defined as a functional limitation in one or more domains of the Washington Group/UNICEF Child Functioning Module administered as part of a community-based census. Treatment of all children during SBD and CBD was independently observed and recorded. For both intervention types, we performed bivariate analyses (z-score) of the absolute proportion of children with and without disabilities treated (absolute differences (ADs) in receipt of treatment), and logistic regression to examine whether disability status was associated with the likelihood of treatment (relative differences in receipt of treatment).

resultsThe overall prevalence of disability was 3.3% (n=1467), and the most common domains of disability were hearing, remembering and communication. Boys were consistently more likely to have a disability compared with girls at all age groups, and disability was strongly associated with lower school attendance and worse levels of education. There was no significant difference in the proportion of children with disabilities treated during SBD when assessed by direct observation (-1% AD, p=0.41) or likelihood of treatment (adjusted risk ratio (aRR)=1.07, 95% CI 0.89 to 1.28). Treatment of all children during CBD was substantially higher than SBD, but again showed no significant difference in the proportions treated (-0.5% AD, p=0.59) or likelihood of treatment (aRR=1.04, 95% CI 0.99 to 1.10).

conclusionSBD does not appear to exclude children with disabilities, but the effect of consistently lower levels of educational participation of children with disabilities should be actively considered in the design and monitoring of school health interventions. TRIAL REGISTRATION NUMBER: NCT03014167.

Indexed as

HelminthiasisMass Drug AdministrationSoilAdolescentAnthelminticsChildChild, PreschoolChildren with DisabilitiesCross-Sectional StudiesFemaleHumansMalawiMalePrevalenceSchool Health ServicesAnthelminticsSoilDisabled PersonsMass Drug AdministrationNeglected DiseasesSchools

Identifiers

PMID39242171
PMCPMC11381638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.